PHIO PHARMACEUTICALS CORP. Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised
PHIO PHARMACEUTICALS CORP. (PHIO) reported Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised of $1.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans · last filed 2021-03-25
- PHIO PHARMACEUTICALS CORP. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2020-12-31 was $0.00.
- PHIO PHARMACEUTICALS CORP. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2020-09-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2020-03-31 was $1.00K.
- PHIO PHARMACEUTICALS CORP. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2020 was $1.00K, a 0.00% change from fiscal 2019.
- PHIO PHARMACEUTICALS CORP. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2019 was $1.00K, a 66.67% decline from fiscal 2018.
- PHIO PHARMACEUTICALS CORP. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2018 was $3.00K, a 50.00% increase from fiscal 2017.
- PHIO PHARMACEUTICALS CORP. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2017 was $2.00K.
| Period end | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 3 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 6 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 9 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $1.00K 10-K · filed 2021-03-25 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $0.00 derived: sum of 2 quarters · filed 2020-11-10 | $1.00K 10-Q · filed 2020-11-10 | $1.00K derived: sum of 4 quarters · filed 2021-03-25 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $1.00K 10-Q · filed 2020-08-12 | $1.00K derived: sum of 3 quarters · filed 2021-03-25 | $1.00K derived: sum of 4 quarters · filed 2021-03-25 |
| 2020-03-31 | $1.00K 10-Q · filed 2020-05-12 | $1.00K derived: sum of 2 quarters · filed 2021-03-25 | $1.00K derived: sum of 3 quarters · filed 2021-03-25 | $2.00K derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $1.00K derived: sum of 3 quarters · filed 2021-03-25 | $1.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $1.00K derived: sum of 2 quarters · filed 2020-11-10 | $1.00K 10-Q · filed 2020-11-10 | $3.00K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $1.00K 10-Q · filed 2020-08-12 | $3.00K derived: sum of 3 quarters · filed 2020-08-12 | $4.00K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-12 | $2.00K derived: sum of 2 quarters · filed 2020-05-12 | $3.00K derived: sum of 3 quarters · filed 2020-05-12 | |
| 2018-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $3.00K derived: sum of 2 quarters · filed 2020-03-26 | $3.00K 10-K · filed 2020-03-26 | |
| 2018-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-12 | |||
| 2017-12-31 | $2.00K 10-K · filed 2019-03-27 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $0.00 derived: sum of 2 quarters · filed 2017-03-30 | $31.00K 10-K · filed 2017-03-30 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $31.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $31.00K 10-Q · filed 2016-08-11 | |||
| 2014-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $31.00K derived: sum of 2 quarters · filed 2016-03-30 | $61.00K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $30.00K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $30.00K 10-Q · filed 2015-08-12 | |||
| 2013-12-31 | $28.00K 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |